New Strategies for the Development of Metal-Based Radiopharmaceuticals for the Diagnosis and Therapy of Cancer
Thomas Mindt (Invited speaker)
Activity: Talks and presentations › Talk or oral contribution › Science to Science
Synthesis and Preclinical Evaluation of BOLD-100 Radiolabeled with Ruthenium-97/103
Thomas Mindt (Speaker)
Activity: Talks and presentations › Talk or oral contribution › Science to Science
Metabolically Stabilized Triazolo-Peptidomimetics for Improved Tumor-Targeting
Thomas Mindt (Invited speaker)
Activity: Talks and presentations › Talk or oral contribution › Science to Science
Radioactive Labeled Molecules for Diagnosis and Therapy of Cancer
Thomas Mindt (Invited speaker)
Activity: Talks and presentations › Talk or oral contribution › Science to Science
Evaluation of two albumin-targeting moieties as in situ binders in comparison to maleimide
Anja Federa (Speaker), H. Schueffl (Contributor), Alexander Kastner (Contributor), Julia Kronberger (Contributor), Bernhard Keppler (Contributor), Thomas Mindt (Contributor), P. Heffeter (Contributor) & Christian Kowol (Contributor)
Activity: Talks and presentations › Talk or oral contribution › Science to Science
Radiometal-Based Radiopharmaceuticals for Theranostic Approaches in Nuclear Medicine
Thomas L. Mindt (Keynote speaker)
Activity: Talks and presentations › Talk or oral contribution › Science to Science
Theranostic Approaches in Radiopharmaceutical Sciences
Thomas L. Mindt (Invited speaker)
Activity: Talks and presentations › Talk or oral contribution › Science to Science
Metabolically Stabilized Triazolo-Peptidomimetics for Tumor Targeting
Thomas Mindt (Speaker)
Activity: Talks and presentations › Talk or oral contribution › Science to Science
Radiolabeling of [89Zr]Zr-Atezolizumab for its clinical evaluation in patient stratification for PD-L1 immune checkpoint inhibition therapy
Julia Kronberger (Speaker), Thomas Mindt (Contributor), Elisabeth de Vries (Contributor) & Marie Brandt (Contributor)
Activity: Talks and presentations › Talk or oral contribution › Science to Science
Auger electron therapy for cancer treatment
Maximilian Anderla (Speaker) & Thomas Mindt (Contributor)
Activity: Talks and presentations › Talk or oral contribution › Science to Science
Peptide-based Radiotracers for PD-L1 PET imaging
Nedra Jouini (Speaker) & Thomas Mindt (Contributor)
Activity: Talks and presentations › Talk or oral contribution › Science to Science
Radiolabeling of [89Zr]Zr-Atezolizumab for its clinical evaluation in patient stratification for PD-L1 immune checkpoint inhibition therapy
Julia Kronberger (Speaker), E. de Vries (Contributor), Marie Brandt (Contributor) & Thomas Mindt (Contributor)
Activity: Talks and presentations › Talk or oral contribution › Science to Science
First-in-human brain imaging of the GluN2B-containing N-methyl-D-aspartate receptor with (R)-11C-Me-NB1 PET
Lucas Rischka (Speaker), Chrysoula Vraka (Contributor), Verena Pichler (Contributor), Sazan Rasul (Contributor), Lukas Nics (Contributor), Gregor Gryglewski (Contributor), Patricia A. Handschuh (Contributor), Matej Murgaš (Contributor), G. N. Godbersen (Contributor), Leo Silberbauer (Contributor), M. Unterholzner (Contributor), C. Wotawa (Contributor), A. Haider (Contributor), H. Ahmed (Contributor), Roger Schibli (Contributor), Thomas Mindt (Contributor), Markus Mitterhauser (Contributor), Wolfgang Wadsak (Contributor), A. Hahn (Contributor), Rupert Lanzenberger (Contributor), Markus Hacker (Contributor) & Simon M. Ametamey (Contributor)
Activity: Talks and presentations › Talk or oral contribution › Science to Science
Radioactive labeled molecules for diagnosis and therapy of diseases
Thomas Mindt (Invited speaker)
Activity: Talks and presentations › Talk or oral contribution › Science to Science
Development of Radiometal-Based Theranostics
Thomas Mindt (Invited speaker)
Activity: Talks and presentations › Talk or oral contribution › Science to Science
Of Emerging and Established Radiometals
Thomas Mindt (Invited speaker)
Activity: Talks and presentations › Talk or oral contribution › Science to Science
Radiometal-Labelled Peptides and Proteins for Diagnosis and Therapy in Nuclear Medicine
Thomas Mindt (Invited speaker)
Activity: Talks and presentations › Talk or oral contribution › Science to Science
Jährliche Tagung der Arbeitsgemeinschaft Radiopharmazie und Radiochemie
Thomas Mindt (Speaker)
Activity: Talks and presentations › Talk or oral contribution › Science to Science
Matching a Radiometal with a Suitable Chelator - A Case Study for 89Zr-ImmunoPET
Thomas Mindt (Speaker)
Activity: Talks and presentations › Talk or oral contribution › Science to Science
Zirkonium-89 für ImmunoPET in der Nuklearmedizin
Thomas Mindt (Speaker)
Activity: Talks and presentations › Talk or oral contribution › Science to Science
Metabolically Stable Triazolo Peptidomimetics for Improved Tumour Targeting
Thomas Mindt (Speaker)
Activity: Talks and presentations › Talk or oral contribution › Science to Science
Bi-Metallic Complexes for Synergistic-Theranostic Application
1/08/22 → 31/07/25
Project: Research funding
Marker für die Aktivität von Albumin-bindenden Verbindungen
Heffeter, P., Mindt, T. & Kowol, C.
1/08/20 → 31/07/24
Project: Research funding
Improved Tumour Targeting with Radiolabelled Peptidomimetics
Kandioller, W., Mindt, T. & Nock, B.
1/10/18 → 30/09/23
Project: Research funding
Department of Inorganic Chemistry
Deputy Head
Strahlenschutzbeauftragter
Währinger Straße 42
1090 Wien
T: +43-1-4277-52690